This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985
Title: The Innovative Mind of Tatsuo Itoh
Introduction
Tatsuo Itoh, an esteemed inventor hailing from Isehara, Japan, has made significant contributions to the field of antibiotics. With a unique approach to antibiotic development, he has secured a patent that showcases his capability and expertise in microbiology.
Latest Patents
His notable patent, titled "Antibiotic SF-2288 and its preparation method," centers around a novel antibiotic produced through the fermentation of an actinomycete belonging to the genus Actinomadura in nutrient medium. This innovative antibiotic demonstrates excellent antimicrobial activity against both Gram-positive and Gram-negative microorganisms, as well as promising antiviral activity. This breakthrough reflects the growing need for effective treatments against resistant pathogens.
Career Highlights
Tatsuo Itoh is currently associated with Meiji Seika Kaisha, Ltd., a prominent company known for its commitment to pharmaceutical advancements. His work there highlights his dedication to improving public health through innovative solutions and impactful research.
Collaborations
Throughout his career, Tatsuo Itoh has worked alongside equally talented individuals such as Yasumitsu Kondo and Takashi Shomura. These collaborations have enriched his research endeavors and contributed to the development of groundbreaking medical therapies.
Conclusion
In conclusion, Tatsuo Itoh stands out as a visionary inventor in the realm of antibiotics. His contributions, particularly through the creation of Antibiotic SF-2288, underscore his role in addressing significant health challenges. With a promising career at Meiji Seika Kaisha, Ltd. and a dedication to scientific exploration, Itoh continues to pave the way for future innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
